CCL22 and neoplasm: CCR4 and its ligands CCL17 and CCL22 have been shown to mediate stimulatory signals for angiogenesis and tumor growth, and CCR4 blockade was associated with reduced tumor invasion and metastasis and better prognosis in some human cancer types such as hepatoma and colon cancer (15, 42).